Virtu Financial LLC Reduces Holdings in Medidata Solutions Inc (NASDAQ:MDSO)

Virtu Financial LLC trimmed its holdings in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 53.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,899 shares of the company’s stock after selling 3,294 shares during the quarter. Virtu Financial LLC’s holdings in Medidata Solutions were worth $265,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Alpine Associates Management Inc. purchased a new stake in Medidata Solutions during the second quarter valued at approximately $130,872,000. Syquant Capital Sas boosted its stake in shares of Medidata Solutions by 348.5% during the 3rd quarter. Syquant Capital Sas now owns 1,550,606 shares of the company’s stock worth $141,880,000 after acquiring an additional 1,204,864 shares during the last quarter. Magnetar Financial LLC bought a new stake in shares of Medidata Solutions during the 2nd quarter valued at $70,980,000. Assenagon Asset Management S.A. bought a new stake in shares of Medidata Solutions during the 3rd quarter valued at $50,333,000. Finally, Echo Street Capital Management LLC grew its position in shares of Medidata Solutions by 82.3% during the 2nd quarter. Echo Street Capital Management LLC now owns 1,044,848 shares of the company’s stock valued at $94,569,000 after acquiring an additional 471,628 shares during the period. Institutional investors own 93.30% of the company’s stock.

MDSO opened at $92.22 on Friday. The firm has a market cap of $5.76 billion, a P/E ratio of 96.06, a PEG ratio of 6.95 and a beta of 1.22. Medidata Solutions Inc has a 1-year low of $60.10 and a 1-year high of $98.60. The company has a 50 day simple moving average of $92.17 and a two-hundred day simple moving average of $91.53. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.56 and a quick ratio of 2.56.

A number of equities analysts recently commented on the company. BidaskClub raised Medidata Solutions from a “sell” rating to a “hold” rating in a report on Tuesday, October 1st. ValuEngine lowered Medidata Solutions from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Finally, Zacks Investment Research upgraded Medidata Solutions from a “hold” rating to a “buy” rating and set a $96.00 price target for the company in a research report on Wednesday, October 23rd. Ten research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Medidata Solutions has an average rating of “Hold” and a consensus target price of $87.35.

Medidata Solutions Profile

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.

Read More: How are the companies in the S&P 500 selected?

Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions Inc (NASDAQ:MDSO).

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit